Correlation Between Estrella Immunopharma and Equillium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and Equillium, you can compare the effects of market volatilities on Estrella Immunopharma and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Equillium.

Diversification Opportunities for Estrella Immunopharma and Equillium

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Estrella and Equillium is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Equillium go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and Equillium

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 0.12 times more return on investment than Equillium. However, Estrella Immunopharma is 8.41 times less risky than Equillium. It trades about 0.0 of its potential returns per unit of risk. Equillium is currently generating about -0.16 per unit of risk. If you would invest  9.10  in Estrella Immunopharma on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Estrella Immunopharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy27.27%
ValuesDaily Returns

Estrella Immunopharma  vs.  Equillium

 Performance 
       Timeline  
Estrella Immunopharma 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Estrella Immunopharma are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Estrella Immunopharma and Equillium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Estrella Immunopharma and Equillium

The main advantage of trading using opposite Estrella Immunopharma and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.
The idea behind Estrella Immunopharma and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stocks Directory
Find actively traded stocks across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk